Calico Life Sciences is a company within the Biotechnology category. Calico Life Sciences (Calico) is an Alphabet-funded research and development company dedicated to the study of aging and age-related diseases. Founded in 2013, the company integrates advanced technology with biological research to understand the mechanisms that govern lifespan and develop interventions that enable people to lead longer and healthier lives.
Calico Life Sciences was founded in 2013 and is headquartered in South San Francisco, CA.
Calico Life Sciences is rated Leader on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Calico Life Sciences is Moderate. Significant factual deltas detected.
AI models classify Calico Life Sciences as a Challenger. AI names competitors first.
Calico Life Sciences appeared in 6 of 8 sampled buyer-intent queries (75%). Calico dominates branded searches and high-level longevity queries but is less visible in specific 'disease-state' searches because it does not market products to consumers or clinicians yet.
AI will reliably identify the brand as Alphabet's 'moonshot' for longevity, citing its blue-chip leadership and AbbVie partnership. However, it will likely struggle to provide concrete updates on its current therapeutic pipeline or commercial timeline. Key gap: The gap between Calico's massive capitalization/resource access and the lack of publicly visible, marketed pharmaceutical products.
Of 6 key facts verified about Calico Life Sciences, 4 are well-documented (likely accurate across AI models), 1 have limited sourcing, and 1 are retrieval-dependent and may be inaccurate without live search.
Product-level detail; it is highly likely that AI will fail to name specific current drug candidates or therapeutic targets due to the company's 'stealth' operating mode.
Buyers turn to Calico Life Sciences for Academic Research Grants: Relying on traditional academic labs and medical research institutions to study aging and provide data., Conventional Healthcare R&D: Following standard clinical trials and waiting for governmental health agencies to release longitudinal study results., among 2 documented problem areas.
Buyers evaluating Calico Life Sciences typically ask AI models about "who is studying the biology of aging", "Alphabet longevity company", "top anti-aging biotech firms", and 3 similar queries.
Calico Life Sciences's main competitors are Altos Labs. According to AI models, these are the brands most frequently named alongside Calico Life Sciences in buyer-intent queries.
Calico Life Sciences's core products are Basic biological research, therapeutic discovery platforms, longevity science data..
Calico Life Sciences uses Enterprise/B2B (Partnerships/Licensing).
Calico Life Sciences serves Pharmaceutical companies, research institutions, healthcare systems..
Calico Life Sciences Unparalleled long-term capital backing from Alphabet allows for 'slow-science' and basic research that traditional venture-backed biotechs cannot afford.
Brand Authority Index (BAI) tier: Leader (exact score locked for unclaimed brands)
Archetype: Challenger
https://optimly.ai/brand/calico-life-sciences
Last analyzed: April 10, 2026
Founded: 2013
Headquarters: South San Francisco, California, USA